Showing results (51-60 of 64) with videos related to
Sort By:
Pageof 7
Plos One|July 31, 2026
The quality of care for type 2 diabetes mellitus management in Malaysian primary health care settings: A scoping review of ABC (glycated haemoglobin A1c, blood pressure, and LDL-cholesterol)Mohamad Zulfikrie Abas, Norshahiratul Atiqah Mohd Zaidi, Pei Jia Lee, et al.Journal of Pharmaceutical Policy and Practice|June 7, 2024
Impact evaluation of guidelines on antibiotic utilisation & appropriateness in Malaysian public primary care: an interrupted time series analysisAudrey Huili Lim, Norazida Ab Rahman, Su Miin Ong, et al.Global Heart|March 28, 2022
Trends for Readmission and Mortality After Heart Failure Hospitalisation in Malaysia, 2007 to 2016Yvonne Mei Fong Lim, Su Miin Ong, Stefan Koudstaal, et al.BMC Health Services Research|January 5, 2024
Identifying factors in the provision of intravenous stroke thrombolysis in Malaysia: a multiple case study from the healthcare providers' perspectiveWen Yea Hwong, Sock Wen Ng, Seng Fah Tong, et al.Vaccine|August 27, 2022
Evaluation of BNT162b2 vaccine effectiveness in Malaysia: test negative case-control studyAudrey Huili Lim, Norazida Ab Rahman, Su Miin Ong, et al.Frontiers in Pediatrics|December 18, 2025
Case-control accuracy study for TOY8 digital developmental screening tool for detecting delays among children aged 3-5 yearsTeck-Hock Toh, Yvonne Mei-Fong Lim, Jeffrey Soon-Yit Lee, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 25, 2022
Waning COVID-19 Vaccine Effectiveness for BNT162b2 and CoronaVac in Malaysia: An Observational StudyJing Lian Suah, Masliyana Husin, Peter Seah Keng Tok, et al.JAMA Network Open|August 10, 2022
Assessment of Heterologous and Homologous Boosting With Inactivated COVID-19 Vaccine at 3 Months Compared With Homologous Boosting of BNT162b2 at 6 MonthsEe Vien Low, Peter Seah Keng Tok, Masliyana Husin, et al.Journal of Pharmaceutical Policy and Practice|May 25, 2026
Landscape of national antibiotic utilisation in Malaysia: an analysis of national pharmaceutical sales data from 2019 to 2023Audrey Huili Lim, Norazida Ab Rahman, Siti Nur Su'Aidah Nasarudin, et al.Vaccine|June 6, 2022
Risk of serious adverse events after the BNT162b2, CoronaVac, and ChAdOx1 vaccines in Malaysia: A self-controlled case series studyNorazida Ab Rahman, Ming Tsuey Lim, Fei Yee Lee, et al.Pageof 7